It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Overcoming the restricted axonal regenerative ability that limits functional repair following a central nervous system injury remains a challenge. Here we report a regenerative paradigm that we call enriched conditioning, which combines environmental enrichment (EE) followed by a conditioning sciatic nerve axotomy that precedes a spinal cord injury (SCI). Enriched conditioning significantly increases the regenerative ability of dorsal root ganglia (DRG) sensory neurons compared to EE or a conditioning injury alone, propelling axon growth well beyond the spinal injury site. Mechanistically, we established that enriched conditioning relies on the unique neuronal intrinsic signaling axis PKC-STAT3-NADPH oxidase 2 (NOX2), enhancing redox signaling as shown by redox proteomics in DRG. Finally, NOX2 conditional deletion or overexpression respectively blocked or phenocopied enriched conditioning-dependent axon regeneration after SCI leading to improved functional recovery. These studies provide a paradigm that drives the regenerative ability of sensory neurons offering a potential redox-dependent regenerative model for mechanistic and therapeutic discoveries.
Pre conditioning injury or environmental enrichment have been shown to promote axon regeneration. Here the authors show that environmental enrichment, combined with preconditioning injury promotes regeneration via a redox signalling dependent mechanism.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Imperial College London, Division of Neuroscience, Department of Brain Sciences, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
2 King’s College London, British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, James Black Centre, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
3 University of Miami, Miami Project to Cure Paralysis, Center for Computational Sciences, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606)
4 Goethe University, Functional Proteomics, Faculty of Medicine, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
5 Imperial College London, Division of Neuroscience, Department of Brain Sciences, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); University of Tuebingen, Laboratory for NeuroRegeneration and Repair, Center for Neurology, Hertie Institute for Clinical Brain Research, Tuebingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)